Moderna Closes Lower After Early Disclosure of Personalized Cancer Vaccine Data 17.57%，AI Major Players Step Up Life Sciences Investment
Moderna Closes Lower After Early Disclosure of Phase Personalized Cancer Vaccine Data 17.57%, but the trial results remain positive. OpenAI, Anthropic, Nvidia, and Merck KGaA have recently continued to advance their life sciences initiatives.